Montreal Heart Institute

NCT07257198

Phase 3, Recruiting, 2026, 2,570 people, 2 Dec 2025, clinicaltrials.gov

Deployment and Evaluation of Artificial Intelligence Software for Electrocardiogram Analysis and Management in Primary Care

No phase, Enrolling by invitation, 2025, 2,000 people, 15 Oct 2024, clinicaltrials.gov

NCT06217120

Phase 2/3, Status unknown, 2024, 60 people, 22 Jan 2024, clinicaltrials.gov

COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes

Phase 3, Recruiting, 2022, 10,000 people, 1 Dec 2022, clinicaltrials.gov

NCT04907253

Phase 2, Completed, 2021, 100 people, 28 May 2021, clinicaltrials.gov

NCT04857931

Phase 2, Terminated, 2022, 14 people, 23 Apr 2021, clinicaltrials.gov

NCT04322682

Phase 3, Terminated, 2020, 4,506 people, 26 Mar 2020, clinicaltrials.gov

NCT02551094

Phase 3, Completed, 2015, 4,745 people, 16 Sept 2015, clinicaltrials.gov

NCT02162303

Phase 2, Completed, 2014, 106 people, 12 Jun 2014, clinicaltrials.gov

NCT01586442

Phase 3, Completed, 2012, 62 people, 26 Apr 2012, clinicaltrials.gov